Thus, the inability of selenite supplementation to enhance GPx3 in established obesity can explain why obesity prevents a supplemented Se-induced insulin-sensitizing effect in adipose tissue. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.